Introducing the Channel Methods Clinical Intelligence Platform Purpose-Built Clinical Trial Intelligence for Life Sciences
Business development teams spend hours every week scanning press releases, trial registries, and industry news for relevant updates. Much of that time is spent sorting through information that never leads to a qualified opportunity.
The Channel Methods Clinical Intelligence Platform eliminates that inefficiency. Designed for CDMOs, CMOs, and CROs, it delivers curated, high-value clinical trial opportunities directly to your inbox each morning. Every opportunity is validated, scored, and ready for outreach, so your team can focus on building relationships instead of collecting data.
What It Delivers
- Opportunity scoring based on your company’s ideal customer profile
- Filtering that removes more than 90 percent of irrelevant results
- A branded daily email digest with structured, actionable information
- Optional contact intelligence with verified decision-maker details
- Implementation in 24 hours
The result is a consistent, high-quality flow of qualified opportunities and reliable market awareness without the time burden of manual research.
Learn more about the Clinical Intelligence Platform and how it supports growth for life science service organizations.
Custom HubSpot for Life Sciences
Configured for Growth. Optimized for Speed.
Channel Methods’ Custom HubSpot implementation is built for the way life science companies sell. It comes preloaded with validated data, tailored workflows, and tools that help sales and marketing teams move faster.
- Segmented contact and company data tailored to your market
- Preconfigured workflows that align with life science buying cycles
- Tools that support faster and more accurate outreach
- Integration with the Clinical Intelligence Platform for account insights
Start using a CRM that supports your team’s strategy from day one.
Life Science & Pharma Spotlight
- BIOSECURE Act Advances in the US Senate – The Senate passed the BIOSECURE Act as part of the National Defense Authorization Act, introducing new sourcing and compliance requirements for U.S. biotech companies.
- FDA Looks to Simplify Biosimilar Development with New Draft Guidance – The FDA released new draft guidance designed to streamline biosimilar approval pathways and reduce costs for manufacturers.
- Biotech Is Back: What’s Driving the Sector Higher – After a challenging few years, biotech stocks are seeing renewed momentum, driven by innovation, M&A activity, and increased investor confidence.
Building Intelligence-Driven Commercial Teams
The most successful commercial organizations in life sciences share one advantage: alignment. When sales, marketing, and operations have access to the same structured information, they can plan and execute with confidence.
Channel Methods develops tools and strategies that connect those functions, from lead intelligence to CRM configuration to targeted outreach.
Together, these solutions reduce friction, increase productivity, and help teams focus on meaningful business growth.
See how Channel Methods helps life science organizations scale smarter.
Services at a Glance
- Inside Sales: Experienced reps who know how to open the right doors
- Marketing Execution: Strategy-to-launch campaign support that fills the top of your funnel
- CRM Optimization: Clean, smart, scalable HubSpot builds made for life sciences
- Campaign Strategy: Outreach plans aligned to market, trial phase, or modality
Recent post
